Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Lily, Novo cut prices on Wegovy and Zepbound in exchange for deal on tariffs
Posted
November 6, 2025
Views
3,231
Likes
27
Comments
7
Engagement
November 6, 2025
3,231
27
7
1.05%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:48Now PlayingEli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. President Trump spoke about the deal earlier today from the Oval Office. The companies' products will receive a three-year grace period from Trump's forthcoming duties on pharmaceutical imports and will be available to certain people on Medicare at a lower cost. Bloomberg's Robert Langreth joined Norah Mulinda and Bailey Lipschultz on 'Bloomberg Businessweek Daily' to break it down.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
